Literature DB >> 22466659

The adaptive immune system in diseases of the central nervous system.

David C Wraith1, Lindsay B Nicholson.   

Abstract

Tissues of the CNS, such as the brain, optic nerves, and spinal cord, may be affected by a range of insults including genetic, autoimmune, infectious, or neurodegenerative diseases and cancer. The immune system is involved in the pathogenesis of many of these, either by causing tissue damage or alternatively by responding to disease and contributing to repair. It is clearly vital that cells of the immune system patrol the CNS and protect against infection. However, in contrast to other tissues, damage caused by immune pathology in the CNS can be irreparable. The nervous and immune systems have, therefore, coevolved to permit effective immune surveillance while limiting immune pathology. Here we will consider aspects of adaptive immunity in the CNS and the retina, both in the context of protection from infection as well as cancer and autoimmunity, while focusing on immune responses that compromise health and lead to significant morbidity.

Entities:  

Mesh:

Year:  2012        PMID: 22466659      PMCID: PMC3314451          DOI: 10.1172/JCI58648

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  98 in total

Review 1.  Antigen-specific therapy for autoimmune disease.

Authors:  L C Harrison; D A Hafler
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

Review 2.  The physiology of lymphocyte migration through the single lymph node in vivo.

Authors:  A J Young
Journal:  Semin Immunol       Date:  1999-04       Impact factor: 11.130

3.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

Authors:  Melanie Greter; Frank L Heppner; Maria P Lemos; Bernhard M Odermatt; Norbert Goebels; Terri Laufer; Randolph J Noelle; Burkhard Becher
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

4.  Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.

Authors:  Emma C Kerr; Ben J E Raveney; David A Copland; Andrew D Dick; Lindsay B Nicholson
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

5.  Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Authors:  Michael J Keating; Ian Flinn; Vinay Jain; Jacques-Louis Binet; Peter Hillmen; John Byrd; Maher Albitar; Lee Brettman; Pedro Santabarbara; Bret Wacker; Kanti R Rai
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.

Authors:  Erik Kwidzinski; Jörg Bunse; Orhan Aktas; Daniel Richter; Leman Mutlu; Frauke Zipp; Robert Nitsch; Ingo Bechmann
Journal:  FASEB J       Date:  2005-06-06       Impact factor: 5.191

7.  Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.

Authors:  R M Mathew; R Vandenberghe; A Garcia-Merino; T Yamamoto; J C Landolfi; M R Rosenfeld; J E Rossi; B Thiessen; E J Dropcho; J Dalmau
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Initiation of immune responses in brain is promoted by local dendritic cells.

Authors:  Jozsef Karman; Changying Ling; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

View more
  44 in total

Review 1.  Fibrosis: ultimate and proximate causes.

Authors:  Victor J Thannickal; Yong Zhou; Amit Gaggar; Steven R Duncan
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Lessons learned at the intersection of immunology and neuroscience.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening.

Authors:  Pin-Yuan Chen; Kuo-Chen Wei; Hao-Li Liu
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

Review 4.  Nanomaterial applications in multiple sclerosis inflamed brain.

Authors:  Clara Ballerini; Giovanni Baldi; Alessandra Aldinucci; Pietro Maggi
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-24       Impact factor: 4.147

5.  Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.

Authors:  Anna Carolina Carvalho da Fonseca; Huaqing Wang; Haitao Fan; Xuebo Chen; Ian Zhang; Leying Zhang; Flavia Regina Souza Lima; Behnam Badie
Journal:  J Neuroimmunol       Date:  2014-06-27       Impact factor: 3.478

Review 6.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 7.  Fate of microglia during HIV-1 infection: From activation to senescence?

Authors:  Natalie C Chen; Andrea T Partridge; Christian Sell; Claudio Torres; Julio Martín-García
Journal:  Glia       Date:  2016-11-26       Impact factor: 7.452

Review 8.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

Review 9.  Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.

Authors:  Egle Cekanaviciute; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.

Authors:  Gregory J Baker; Peter Chockley; Viveka Nand Yadav; Robert Doherty; Michael Ritt; Sivaraj Sivaramakrishnan; Maria G Castro; Pedro R Lowenstein
Journal:  Cancer Res       Date:  2014-07-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.